Bacteriophage and their lysins for elimination of infectious bacteria: Review article

FEMS Microbiology Reviews

Volumn 33, Issue 4, 2009, Pages 801-819

  O'Flaherty, Sarah ^a,b   Ross, R Paul ^a,c   Coffey, Aidan ^d  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d Ireland   (Ireland)

Author keywords

Antibacterial; Antibiotic resistance; Bacteriophage; Infection; Lysin; Pathogen

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BACTERIOPHAGE LYSIN; CIPROFLOXACIN; PHAGOBIODERM; UNCLASSIFIED DRUG;

ANIMAL DISEASE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIAL SKIN DISEASE; BACTERIOPHAGE; BACTERIUM CONTAMINATION; BACTERIUM IDENTIFICATION; BIOFILM; BIOLOGICAL PEST CONTROL; CROP; FOOD CONTAMINATION; HISTORY OF MEDICINE; HUMAN; LABORATORY DIAGNOSIS; MEAT; NONHUMAN; REVIEW; STAPHYLOCOCCUS INFECTION; VETERINARY MEDICINE;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; BACTERIOPHAGES; BASE SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; MUCOPROTEINS; VIRAL PROTEINS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 66749132773     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1111/j.1574-6976.2009.00176.x     Document Type: Review

References (146)

1. Abuladze T, Li M, Menetrez MY, Dean T, Senecal A Sulakvelidze A (2008) Bacteriophages reduce experimental contamination of hard surfaces, tomato, spinach, broccoli, and ground beef by Escherichia coli O157:H7. Appl Environ Microb 74 : 6230 6238.
2. Atterbury RJ, Connerton PL, Dodd CE, Rees CE Connerton IF (2003) Isolation and characterization of Campylobacter bacteriophages from retail poultry. Appl Environ Microb 69 : 4511 4518. (Pubitemid 36992906)
3. Atterbury RJ, Van Bergen MA, Ortiz F, Lovell MA, Harris JA, De Boer A, Wagenaar JA, Allen VM Barrow PA (2007) Bacteriophage therapy to reduce Salmonella colonization of broiler chickens. Appl Environ Microb 73 : 4543 4549. (Pubitemid 47122599)
4. Barrow P, Lovell M Berchieri A Jr. (1998) Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin Diagn Lab Immun 5 : 294 298. (Pubitemid 28246447)
5. Bayer ME, Thurow H Bayer MH (1979) Penetration of the polysaccharide capsule of Escherichia coli (Bi161/42) by bacteriophage K29. Virology 94 : 95 118. (Pubitemid 9164786)
6. Bergh O, Borsheim KY, Bratbak G Heldal M (1989) High abundance of viruses found in aquatic environments. Nature 340 : 467 468.
7. Biswas B, Adhya S, Washart P, Paul B, Trostel AN, Powell B, Carlton R Merril CR (2002) Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect Immun 70 : 204 210. (Pubitemid 34028619)
8. Boyd EF Brussow H (2002) Common themes among bacteriophage-encoded virulence factors and diversity among the bacteriophages involved. Trends Microbiol 10 : 521 529. (Pubitemid 35284799)
9. Bozdogan B Appelbaum PC (2004) Macrolide resistance in Streptococci and Haemophilus influenzae. Clin Lab Med 24 : 455 475. (Pubitemid 38737261)
10. Bruttin A Brussow H (2005) Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Ch 49 : 2874 2878. (Pubitemid 40917605)
11. Bull JJ, Levin BR, DeRouin T, Walker N Bloch CA (2002) Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol 2 : 35.
12. Carlton RM (1999) Phage therapy: past history and future prospects. Arch Immunol Ther Ex 47 : 267 274.
13. Carlton RM, Noordman WH, Biswas B, de Meester ED Loessner MJ (2005) Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul Toxicol Pharm 43 : 301 312. (Pubitemid 41616396)
14. Cerca N, Oliveira R Azeredo J (2007) Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of Staphylococcus bacteriophage K. Lett Appl Microbiol 45 : 313 317. (Pubitemid 47294735)
15. Cerveny KE, DePaola A, Duckworth DH Gulig PA (2002) Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice. Infect Immun 70 : 6251 6262. (Pubitemid 35192717)
16. Chanishvili N, Chanishvili T, Tediashvili M Barrow PA (2001) Phages and their application against drug-resistant bacteria. J Chem Technol Biot 76 : 689 699. (Pubitemid 32640402)
17. Chen J Novick RP (2009) Phage-mediated intergeneric transfer of toxin genes. Science 323 : 139 141.
18. Cheng Q, Nelson D, Zhu S Fischetti VA (2005) Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Ch 49 : 111 117. (Pubitemid 40065780)
19. Chhibber S, Kaur S Kumari S (2008) Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J Med Microbiol 57 : 1508 1513.
20. Chibani-Chennoufi S, Bruttin A, Dillmann ML Brussow H (2004a) Phage-host interaction: an ecological perspective. J Bacteriol 186 : 3677 3686. (Pubitemid 38746042)
21. Chibani-Chennoufi S, Sidoti J, Bruttin A, Kutter E, Sarker S Brussow H (2004b) In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob Agents Ch 48 : 2558 2569. (Pubitemid 38823425)
22. Cislo M, Dabrowski M, Weber-Dabrowska B Woyton A (1987) Bacteriophage treatment of suppurative skin infections. Arch Immunol Ther Ex 35 : 175 183. (Pubitemid 18075973)
23. Croux C, Ronda C, Lopez R Garcia JL (1993) Interchange of functional domains switches enzyme specificity: construction of a chimeric pneumococcal-clostridial cell wall lytic enzyme. Mol Microbiol 9 : 1019 1025.
24. Diaz E, Lopez R Garcia JL (1990) Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes. P Natl Acad Sci USA 87 : 8125 8129.
25. Diaz E, Lopez R Garcia JL (1991) Chimeric pneumococcal cell wall lytic enzymes reveal important physiological and evolutionary traits. J Biol Chem 266 : 5464 5471. (Pubitemid 21909517)
26. Di Perri G Bonora S (2004) Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis? J Antimicrob Chemoth 54 : 593 602. (Pubitemid 39263899)
27. Donovan DM, Dong S, Garrett W, Rousseau GM, Moineau S Pritchard DG (2006a) Peptidoglycan hydrolase fusions maintain their parental specificities. Appl Environ Microb 72 : 2988 2996.
28. Donovan DM, Lardeo M Foster-Frey J (2006b) Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin. FEMS Microbiol Lett 265 : 133 139. (Pubitemid 44715454)
29. Doolittle MM, Cooney JJ Caldwell DE (1995) Lytic infection of Escherichia coli biofilms by bacteriophage T4. Can J Microbiol 41 : 12 18.
30. Doolittle MM, Cooney JJ Caldwell DE (1996) Tracing the interaction of bacteriophage with bacterial biofilms using fluorescent and chromogenic probes. J Ind Microbiol 16 : 331 341.
31. Entenza JM, Loeffler JM, Grandgirard D, Fischetti VA Moreillon P (2005) Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrob Agents Ch 49 : 4789 4792. (Pubitemid 41552621)
32. Fiorentin L, Vieira ND Barioni W Jr. (2005) Oral treatment with bacteriophages reduces the concentration of Salmonella Enteritidis PT4 in caecal contents of broilers. Avian Pathol 34 : 258 263. (Pubitemid 40832001)
33. Fluit AC (2005) Towards more virulent and antibiotic-resistant Salmonella? FEMS Immunol Med Mic 43 : 1 11. (Pubitemid 40029421)
34. Fortuna W, Miedzybrodzki R, Weber-Dabrowska B Gorski A (2008) Bacteriophage therapy in children: facts and prospects. Med Sci Monitor 14 : RA126 RA132.
35. Gaeng S, Scherer S, Neve H Loessner MJ (2000) Gene cloning and expression and secretion of Listeria monocytogenes bacteriophage-lytic enzymes in Lactococcus lactis. Appl Environ Microb 66 : 2951 2958. (Pubitemid 30497604)
36. Gill JJ, Pacan JC, Carson ME, Leslie KE, Griffiths MW Sabour PM (2006a) Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle. Antimicrob Agents Ch 50 : 2912 2918. (Pubitemid 44396392)
37. Gill JJ, Sabour PM, Leslie KE Griffiths MW (2006b) Bovine whey proteins inhibit the interaction of Staphylococcus aureus and bacteriophage K. J Appl Microbiol 101 : 377 386. (Pubitemid 44060418)
38. Goode D, Allen VM Barrow PA (2003) Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages. Appl Environ Microb 69 : 5032 5036. (Pubitemid 36992978)
39. Goodridge LD (2004) Bacteriophage biocontrol of plant pathogens: fact or fiction? Trends Biotechnol 22 : 384 385. (Pubitemid 38993218)
40. Gorski A, Borysowski J, Miedzybrodzki R Weber-Dabrowska B (2007) Bacteriophages in medicine. Bacteriophage: Genetics and Molecular Biology (McGrath S Van Sinderen D, eds), pp. 125 158. Caister Academic Press, Norfolk, UK.
41. Grandgirard D, Loeffler JM, Fischetti VA Leib SL (2008) Phage lytic enzyme cpl-1 for antibacterial therapy in experimental pneumococcal meningitis. J Infect Dis 197 : 1519 1522.
42. Greer GG (1986) Homologous bacteriophage control of Pseudomonas growth and beef spoilage. J Food Prot 49 : 104 109. (Pubitemid 16086297)
43. Greer GG Dilts BD (1990) Inability of a bacteriophage pool to control beef spoilage. Int J Food Microbiol 10 : 331 342. (Pubitemid 20176315)
44. Greer GG Dilts BD (2002) Control of Brochothrix thermosphacta spoilage of pork adipose tissue using bacteriophages. J Food Prot 65 : 861 863. (Pubitemid 34494841)
45. Guttman B, Raya R Kutter E (2005) Basic phage biology. Bacteriophages, Biology and Applications (Kutter E Sulakvelidze A, eds), pp. 29 66. CRC Press, Boca Raton, FL.
46. Hendrix RW, Smith MC, Burns RN, Ford ME Hatfull GF (1999) Evolutionary relationships among diverse bacteriophages and prophages: all the world's a phage. P Natl Acad Sci USA 96 : 2192 2197. (Pubitemid 29117890)
47. Hendrix RW, Lawrence JG, Hatfull GF Casjens S (2000) The origins and ongoing evolution of viruses. Trends Microbiol 8 : 504 508.
48. Horgan M, O'Flynn G, Garry J, Cooney J, Coffey A, Fitzgerald GF, Ross RP McAuliffe O (2009) The phage lysin, LysK, can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Appl Environ Microb 75 : 872 874.
49. Huff WE, Huff GR, Rath NC, Balog JM Donoghue AM (2002a) Prevention of Escherichia coli infection in broiler chickens with a bacteriophage aerosol spray. Poultry Sci 81 : 1486 1491. (Pubitemid 39615788)
50. Huff WE, Huff GR, Rath NC, Balog JM, Xie H, Moore PA Jr. Donoghue AM (2002b) Prevention of Escherichia coli respiratory infection in broiler chickens with bacteriophage (SPR02). Poultry Sci 81 : 437 441. (Pubitemid 39615829)
51. Huff WE, Huff GR, Rath NC, Balog JM Donoghue AM (2003a) Bacteriophage treatment of a severe Escherichia coli respiratory infection in broiler chickens. Avian Dis 47 : 1399 1405. (Pubitemid 37538166)
52. Huff WE, Huff GR, Rath NC, Balog JM Donoghue AM (2003b) Evaluation of aerosol spray and intramuscular injection of bacteriophage to treat an Escherichia coli respiratory infection. Poultry Sci 82 : 1108 1112. (Pubitemid 38641651)
53. Huff WE, Huff GR, Rath NC, Balog JM Donoghue AM (2004) Therapeutic efficacy of bacteriophage and Baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers. Poultry Sci 83 : 1944 1947. (Pubitemid 39584139)
54. Huff WE, Huff GR, Rath NC, Balog JM Donoghue AM (2005) Alternatives to antibiotics: utilization of bacteriophage to treat colibacillosis and prevent foodborne pathogens. Poultry Sci 84 : 655 659. (Pubitemid 40697365)
55. Huff WE, Huff GR, Rath NC Donoghue AM (2006) Evaluation of the influence of bacteriophage titer on the treatment of colibacillosis in broiler chickens. Poultry Sci 85 : 1373 1377. (Pubitemid 46056552)
56. Jacobs MR (2004) Building in efficacy: developing solutions to combat drug-resistant S. pneumoniae. Clin Microbiol Infec 10 (suppl 2) : 18 27. (Pubitemid 38519350)
57. Jado I, Lopez R, Garcia E, Fenoll A, Casal J Garcia P (2003) Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. J Antimicrob Chemothr 52 : 967 973. (Pubitemid 38008417)
58. Jain R Danziger LH (2004) Multidrug-resistant acinetobacter infections: an emerging challenge to clinicians. Ann Pharmacother 38 : 1449 1459. (Pubitemid 39100202)
59. Jikia D, Chkhaidze N, Imedashvili E, Mgaloblishvili I, Tsitlanadze G, Katsarava R, Morris JG Jr. Sulakvelidze A (2005) The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infected local radiation injuries caused by exposure to Sr90. Clin Exp Dermatol 30 : 23 26. (Pubitemid 40188311)
60. Lang LH (2006) FDA approves use of bacteriophages to be added to meat and poultry products. Gastroenterology 131 : 1370. (Pubitemid 44708973)
61. Leverentz B, Conway WS, Alavidze Z, Janisiewicz WJ, Fuchs Y, Camp MJ, Chighladze E Sulakvelidze A (2001) Examination of bacteriophage as a biocontrol method for Salmonella on fresh-cut fruit: a model study. J Food Prot 64 : 1116 1121. (Pubitemid 32763548)
62. Leverentz B, Conway WS, Camp MJ, Janisiewicz WJ, Abuladze T, Yang M, Saftner R Sulakvelidze A (2003) Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. Appl Environ Microb 69 : 4519 4526. (Pubitemid 36992907)
63. Leverentz B, Conway WS, Janisiewicz W Camp MJ (2004) Optimizing concentration and timing of a phage spray application to reduce Listeria monocytogenes on honeydew melon tissue. J Food Prot 67 : 1682 1686. (Pubitemid 39059268)
64. Lindmark H, Harbom B, Thebo L, Andersson L, Hedin G, Osterman B, Lindberg T, Andersson Y, Westoo A Olsson Engvall E (2004) Genetic characterization and antibiotic resistance of Campylobacter jejuni isolated from meats, water, and humans in Sweden. J Clin Microbiol 42 : 700 706. (Pubitemid 38222649)
65. Linkous DA Oliver JD (1999) Pathogenesis of Vibrio vulnificus. FEMS Microbiol Lett 174 : 207 214. (Pubitemid 29217008)
66. Loc Carrillo C, Atterbury RJ, el-Shibiny A, Connerton PL, Dillon E, Scott A Connerton IF (2005) Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens. Appl Environ Microb 71 : 6554 6563. (Pubitemid 43194136)
67. Loeffler JM Fischetti VA (2003) Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains. Antimicrob Agents Ch 47 : 375 377. (Pubitemid 36070389)
68. Loeffler JM, Nelson D Fischetti VA (2001) Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294 : 2170 2172. (Pubitemid 33150674)
69. Loeffler JM, Djurkovic S Fischetti VA (2003) Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect Immun 71 : 6199 6204. (Pubitemid 37337675)
70. Loessner MJ, Schneider A Scherer S (1995a) A new procedure for efficient recovery of DNA, RNA, and proteins from Listeria cells by rapid lysis with a recombinant bacteriophage endolysin. Appl Environ Microb 61 : 1150 1152.
71. Loessner MJ, Wendlinger G Scherer S (1995b) Heterogeneous endolysins in Listeria monocytogenes bacteriophages: a new class of enzymes and evidence for conserved holin genes within the siphoviral lysis cassettes. Mol Microbiol 16 : 1231 1241.
72. Lopez R Garcia E (2004) Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage. FEMS Microbiol Rev 28 : 553 580. (Pubitemid 39469920)
73. López R, García E García P (2004) Enzymes for anti-infective therapy: phage lysins. Drug Discov Today 1 : 469 474. (Pubitemid 40197593)
74. Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111 : 1265 1273. (Pubitemid 36554694)
75. Lu TK Collins JJ (2007) Dispersing biofilms with engineered enzymatic bacteriophage. P Natl Acad Sci USA 104 : 11197 11202. (Pubitemid 47175118)
76. Matsuzaki S, Yasuda M, Nishikawa H et al 2003) Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J Infect Dis 187 : 613 624. (Pubitemid 36250025)
77. McCullers JA, Karlstrom A, Iverson AR, Loeffler JM Fischetti VA (2007) Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. PLoS Pathog 3 : e28.
78. Mc Grath S Van Sinderen D (2007) Bacteriophage Genetics and Molecular Biology. Caister Academic Press, Norfolk, UK.
79. McLauchlin J, Mitchell RT, Smerdon WJ Jewell K (2004) Listeria monocytogenes and listeriosis: a review of hazard characterisation for use in microbiological risk assessment of foods. Int J Food Microbiol 92 : 15 33. (Pubitemid 38368049)
80. McVay CS, Velasquez M Fralick JA (2007) Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob Agents Ch 51 : 1934 1938. (Pubitemid 46903076)
81. Megraud F (2004) H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53 : 1374 1384. (Pubitemid 39120130)
82. Merril CR, Biswas B, Carlton R, Jensen NC, Creed GJ, Zullo S Adhya S (1996) Long-circulating bacteriophage as antibacterial agents. P Natl Acad Sci USA 93 : 3188 3192. (Pubitemid 26125592)
83. Nakai T Park SC (2002) Bacteriophage therapy of infectious diseases in aquaculture. Res Microbiol 153 : 13 18. (Pubitemid 34112573)
84. Nakai T, Sugimoto R, Park KH, Matsuoka S, Mori K, Nishioka T Maruyama K (1999) Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail. Dis Aquat Organ 37 : 33 41. (Pubitemid 29337543)
85. Nelson D, Loomis L Fischetti VA (2001) Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. P Natl Acad Sci USA 98 : 4107 4112. (Pubitemid 32249906)
86. Nishikawa H, Yasuda M, Uchiyama J et al 2008) T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections. Arch Virol 153 : 507 515.
87. Norrby SR, Nord CE Finch R (2005) Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 5 : 115 119. (Pubitemid 40174782)
88. Obeso JM, Martinez B, Rodriguez A Garcia P (2008) Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk. Int J Food Microbiol 128 : 212 218.
89. O'Flaherty S, Coffey A, Edwards R, Meaney W, Fitzgerald GF Ross RP (2004) Genome of staphylococcal phage K: a new lineage of Myoviridae infecting Gram-positive bacteria with a low G+C content. J Bacteriol 186 : 2862 2871. (Pubitemid 38525941)
90. O'Flaherty S, Coffey A, Meaney W, Fitzgerald GF Ross RP (2005a) The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol 187 : 7161 7164. (Pubitemid 41428894)
91. O'Flaherty S, Coffey A, Meaney WJ, Fitzgerald GF Ross RP (2005b) Inhibition of bacteriophage K proliferation on Staphylococcus aureus in raw bovine milk. Lett Appl Microbiol 41 : 274 279. (Pubitemid 41232375)
92. O'Flaherty S, Ross RP, Flynn J, Meaney WJ, Fitzgerald GF Coffey A (2005c) Isolation and characterization of two anti-staphylococcal bacteriophages specific for pathogenic Staphylococcus aureus associated with bovine infections. Lett Appl Microbiol 41 : 482 486. (Pubitemid 41735619)
93. O'Flaherty S, Ross RP, Meaney W, Fitzgerald GF, Elbreki MF Coffey A (2005d) Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. Appl Environ Microb 71 : 1836 1842. (Pubitemid 40546101)
94. O'Flynn G, Ross RP, Fitzgerald GF Coffey A (2004) Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7. Appl Environ Microb 70 : 3417 3424. (Pubitemid 38745886)
95. O'Flynn G, Coffey A, Fitzgerald GF Ross RP (2006) The newly isolated lytic bacteriophages st104a and st104b are highly virulent against Salmonella enterica. J Appl Microbiol 101 : 251 259. (Pubitemid 43952024)
96. O'Flynn G, Coffey A, Fitzgerald G Ross RP (2007) Salmonella enterica phage-resistant mutant colonies display an unusual phenotype in the presence of phage Felix 01. Lett Appl Microbiol 45 : 581 585. (Pubitemid 350150782)
97. Ong CT, Kuti JL, Nightingale CH Nicolau DP (2004) Emerging Pseudomonas aeruginosa resistance: implications in clinical practise. Conn Med 68 : 11 15. (Pubitemid 38040231)
98. Park SC Nakai T (2003) Bacteriophage control of Pseudomonas plecoglossicida infection in ayu Plecoglossus altivelis. Dis Aquat Organ 53 : 33 39. (Pubitemid 36199065)
99. Park SC, Shimamura I, Fukunaga M, Mori KI Nakai T (2000) Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control. Appl Environ Microb 66 : 1416 1422. (Pubitemid 30185611)
100. Pritchard DG, Dong S, Baker JR Engler JA (2004) The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology 150 : 2079 2087. (Pubitemid 39117622)
101. Projan SJ Shlaes DM (2004) Antibacterial drug discovery: is it all downhill from here? Clin Microbiol Infec 10 (suppl 4) : 18 22.
102. Ramesh V, Fralick JA Rolfe RD (1999) Prevention of Clostridium difficile-induced ileocecitis with bacteriophage. Anaerobe 5 : 69 78. (Pubitemid 29431598)
103. Rashel M, Uchiyama J, Ujihara T et al 2007) Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. J Infect Dis 196 : 1237 1247. (Pubitemid 47580279)
104. Raya RR, Varey P, Oot RA, Dyen MR, Callaway TR, Edrington TS, Kutter EM Brabban AD (2006) Isolation and characterization of a new T-even bacteriophage, CEV1, and determination of its potential to reduce Escherichia coli O157:H7 levels in sheep. Appl Environ Microb 72 : 6405 6410. (Pubitemid 44414679)
105. Razavi B, Apisarnthanarak A Mundy LM (2007) Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance. Infection 35 : 300 307. (Pubitemid 47502344)
106. Rohwer F Edwards R (2002) The phage proteomic tree: a genome-based taxonomy for phage. J Bacteriol 184 : 4529 4535. (Pubitemid 34832581)
107. Roy B, Ackermann HW, Pandian S, Picard G Goulet J (1993) Biological inactivation of adhering Listeria monocytogenes by listeria phages and a quaternary ammonium compound. Appl Environ Microb 59 : 2914 2917. (Pubitemid 23267083)
108. Saenz Y, Brinas L, Dominguez E, Ruiz J, Zarazaga M, Vila J Torres C (2004) Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins. Antimicrob Agents Ch 48 : 3996 4001. (Pubitemid 39304633)
109. Sanz JM, Garcia P Garcia JL (1996) Construction of a multifunctional pneumococcal murein hydrolase by module assembly. Eur J Biochem 235 : 601 605. (Pubitemid 26061885)
110. Sass P Bierbaum G (2007) Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl Environ Microb 73 : 347 352. (Pubitemid 46079972)
111. Schuch R, Nelson D Fischetti VA (2002) A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418 : 884 889. (Pubitemid 34966308)
112. Schuch R, Fischetti VA Nelson DC (2009) A genetic screen to identify bacteriophage lysins. Method Mol Biol 502 : 307 319.
113. Sheng H, Knecht HJ, Kudva IT Hovde CJ (2006) Application of bacteriophages to control intestinal Escherichia coli O157:H7 levels in ruminants. Appl Environ Microb 72 : 5359 5366. (Pubitemid 44242389)
114. Sillankorva S, Oliveira R, Vieira MJ, Sutherland IW Azeredo J (2004) Bacteriophage Phi S1 infection of Pseudomonas fluorescens planktonic cells versus biofilms. Biofouling 20 : 133 138. (Pubitemid 39533597)
115. Slopek S, Durlakowa I, Kucharewicz-Krukowska B, Dabrowski M Bisikiewicz R (1983) Results of bacteriophage treatment of suppurative bacterial infections. Arch Immunol Ther Ex 31 : 293 327.
116. Slopek S, Weber-Dabrowska B, Dabrowski M Kucharewicz-Krukowska A (1987) Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch Immunol Ther Ex 35 : 569 583.
117. Smith HW Huggins MB (1982) Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 128 : 307 318. (Pubitemid 12159900)
118. Smith HW Huggins MB (1983) Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J Gen Microbiol 129 : 2659 2675.
119. Smith HW, Huggins MB Shaw KM (1987a) Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. J Gen Microbiol 133 : 1127 1135. (Pubitemid 17086128)
120. Smith HW, Huggins MB Shaw KM (1987b) The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol 133 : 1111 1126. (Pubitemid 17086127)
121. Smith HW, Huggins MB Shaw KM (1987c) Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. J Gen Microbiol 133 : 1127 1135. (Pubitemid 17086128)
122. Soothill JS (1994) Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa. Burns 20 : 209 211. (Pubitemid 24163010)
123. Sulakvelidze A (2001) Bacteriophages as therapeutic agents. Ann Med 33 : 507 509. (Pubitemid 33052270)
124. Sulakvelidze A Barrow P (2005) Phage therapy in animals and agribusiness. Bacteriophages Biology and Applications (Kutter E Sulakvelidze A, eds), pp. 335 380. CRC Press, Boca Raton, FL.
125. Sulakvelidze A Kutter E (2005) Bacteriophage therapy in humans. Bacteriophages, Biology and History (Kutter E Sulakvelidze A, eds), pp. 381 436. CRC Press, Boca Raton, FL.
126. Sulakvelidze A, Alavidze Z Morris JG Jr. (2001) Bacteriophage therapy. Antimicrob Agents Ch 45 : 649 659. (Pubitemid 32182003)
127. Summers WC (1999) Felix d'Herelle and the Origins of Molecular Biology. Yale University Press New Haven, CT.
128. Summers WC (2001) Bacteriophage therapy. Annu Rev Microbiol 55 : 437 451. (Pubitemid 32978113)
129. Tanji Y, Shimada T, Fukudomi H, Miyanaga K, Nakai Y Unno H (2005) Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice. J Biosci Bioeng 100 : 280 287. (Pubitemid 41755292)
130. Toro H, Price SB, McKee AS, Hoerr FJ, Krehling J, Perdue M Bauermeister L (2005) Use of bacteriophages in combination with competitive exclusion to reduce Salmonella from infected chickens. Avian Dis 49 : 118 124. (Pubitemid 40383837)
131. Uchiyama J, Rashel M, Takemura I, Wakiguchi H Matsuzaki S (2008) In silico and in vivo evaluation of bacteriophage {phi}EF24C, a candidate for treatment of Enterococcus faecalis infections. Appl Environ Microb 74 : 4149 4163.
132. Vinodkumar CS, Kalsurmath S Neelagund YF (2008) Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice. Indian J Pathol Microbiol 51 : 360 366.
133. Wagenaar JA, Van Bergen MA, Mueller MA, Wassenaar TM Carlton RM (2005) Phage therapy reduces Campylobacter jejuni colonization in broilers. Vet Microbiol 109 : 275 283. (Pubitemid 41073509)
134. Wang J, Hu B, Xu M et al 2006a) Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa. Int J Mol Med 17 : 309 317.
135. Wang J, Hu B, Xu M et al 2006b) Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase- producing Escherichia coli bacteremia. Int J Mol Med 17 : 347 355.
136. Weber-Dabrowska B, Mulczyk M Gorski A (2000) Bacteriophage therapy of bacterial infections: an update of our institute's experience. Arch Immunol Ther Ex 48 : 547 551. (Pubitemid 32108401)
137. Weber-Dabrowska B, Mulczyk M Gorski A (2001) Bacterophage therapy for infections in cancer patients. Clin Applied Immunol Rev 1 : 131 134.
138. Weber-Dabrowska B, Mulczyk M Gorski A (2003) Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. Transplant Proc 35 : 1385 1386. (Pubitemid 36765538)
139. Weinbauer MG (2004) Ecology of prokaryotic viruses. FEMS Microbiol Rev 28 : 127 181. (Pubitemid 38510500)
140. Whichard JM, Sriranganathan N Pierson FW (2003) Suppression of Salmonella growth by wild-type and large-plaque variants of bacteriophage Felix O1 in liquid culture and on chicken frankfurters. J Food Prot 66 : 220 225. (Pubitemid 36178471)
141. Whitman WB, Coleman DC Wiebe WJ (1998) Prokaryotes: the unseen majority. P Natl Acad Sci USA 95 : 6578 6583. (Pubitemid 28278022)
142. Wills QF, Kerrigan C Soothill JS (2005) Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. Antimicrob Agents Ch 49 : 1220 1221. (Pubitemid 40327754)
143. Yoong P, Schuch R, Nelson D Fischetti VA (2004) Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium. J Bacteriol 186 : 4808 4812. (Pubitemid 38891043)
144. Yoong P, Schuch R, Nelson D Fischetti VA (2006) PlyPH, a bacteriolytic enzyme with a broad pH range of activity and lytic action against Bacillus anthracis. J Bacteriol 188 : 2711 2714.
145. Zhang Y (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9 : 40.
146. Zimmer M, Vukov N, Scherer S Loessner MJ (2002) The murein hydrolase of the bacteriophage phi3626 dual lysis system is active against all tested Clostridium perfringens strains. Appl Environ Microb 68 : 5311 5317. (Pubitemid 35265662)